Celldex Therapeutics Inc (NASDAQ:CLDX)

0.5834
Delayed Data
As of Jun 15
 -0.0187 / -3.11%
Today’s Change
0.58
Today|||52-Week Range
3.26
-79.46%
Year-to-Date

Today’s Trading

Previous close0.60
Today’s open0.60
Day’s range0.58 - 0.60
Volume3,777,972
Average volume (3 months)2,872,138
Market cap$103.2M
Data as of 4:00pm ET, 06/15/2018

Growth & Valuation

Earnings growth (last year)+43.31%
Earnings growth (this year)-53.12%
Earnings growth (next 5 years)--
Revenue growth (last year)+87.78%
P/E ratioNM
Price/Sales28.65
Price/Book0.42

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc+0.14+1.61%
OXFDOxford Immunotec Glo...+0.14+1.04%
QTNTQuotient Ltd+0.48+7.21%
TRIBTrinity Biotech PLC-0.07-1.41%
Data as of 4:00pm ET, 06/15/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$12.7M
Annual profit (last year)-$93.0M
Net profit margin-730.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
Chief Financial Officer, Secretary &
Senior VP
Sam Martin
Corporate headquarters
Hampton, New Jersey

Forecasts